Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Botox for sports injuries? small study tests pain relief for stubborn groin pain

NCT ID NCT05430893

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether injecting botulinum toxin A (like Botox) into a groin muscle could ease chronic pain in athletes with athletic pubalgia, a stubborn sports injury. Twenty athletes who had not gotten better with other treatments received one injection. Researchers tracked pain, activity limits, and quality of life over the short term. Because it was a small, observational study without a control group, the results are only a first step and need more research.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
botulinum toxin A
What this could lead to
If it works, this could point toward a new pain relief option for athletes with chronic groin pain who haven't improved with other treatments.
What could go wrong
This was a small, retrospective study with only 20 participants and no comparison group, so results are very preliminary and may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

Jun 2017

Finished

Mar 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with chronic athletic pubalgia for whom medical and/or surgical treatments have failed and who were treated with an intra-muscular injection of botulinum toxin A injection under ultrasound guidance

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * chronic AP * symptom duration ≥ 3 months * consistent clinical and magnetic resonance imaging findings according to the clinician * failure of medical and/or surgical treatments with persistent pain and inability to return to play * treatment with an intra-muscular injection of botulinum toxin A injection Exclusion Criteria: * age under 18 years * ongoing pregnancy or breastfeeding * treatments by anticoagulants * muscular disorder (e.g. polymyositis, myopathy or other neuromuscular conditions) * guardianship or curatorship * individuals who had received botulinum toxin type A treatment for less than one year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Athletic pubalgia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de rééducation fonctionnelle, réadaptation de l'appareil locomoteur et Pathologies du Rachis - Cochin Hospital

    Paris, Île-de-France Region, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.